Treatment of pregnant women affected with polycystic ovary syndrome


Patent Application number: European Procedure (Patents) (EPA) - 31 Mars 2017 - 17 305 385.1
Inventors:
GIACOBINI Paolo,PREVOT Vincent
Publications:
Tata B, Mimouni NEH, Barbotin AL, Malone SA, Loyens A, Pigny P, Dewailly D, Catteau-Jonard S, Sundström-Poromaa I, Piltonen TT, Dal Bello F, Medana C, Prevot V, Clasadonte J and Giacobini P (2018) Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nature Medicine. DOI: 10.1038/s41591-018-0035-5.

Reference:

BIO17095-T1

Business Developper
contact
Inserm Transfert
Business Developer
Patent filling date: 31-03-2017
Rare disease: No
Second indication: No

You might also be interested in